Really enjoyed this summary, the focus on platform technologies like AI protein design, temporal multi-omics, and new delivery methods really stood out. It’s interesting how much attention is shifting toward enabling technologies rather than just new targets or modalities. Curious to hear what you think: are we heading into a decade where platforms outpace individual therapeutic breakthroughs?
Really enjoyed this summary, the focus on platform technologies like AI protein design, temporal multi-omics, and new delivery methods really stood out. It’s interesting how much attention is shifting toward enabling technologies rather than just new targets or modalities. Curious to hear what you think: are we heading into a decade where platforms outpace individual therapeutic breakthroughs?